title: Pattern of elevation of urine catecholamines in intracerebral haemorrhage.
abstract: Autonomic nervous system dysfunction is a common complication of severe intracranial disease. The aim of this study was to reveal the autonomic changes in patients suffering from acute intracerebral haemorrhage (ICH). 25 patients with spontaneous ICH within 24 hours of onset of symptoms were included. All patients were treated with standardised medical management and the meta- and normetanephrines were detected by high performance liquid chromatography (HPLC) in 24-hour urine every day. The mean level of normetanephrine (709 +/- 579 micrograms/day) and metanephrine (244 +/- 161 mg/day) were significantly elevated in comparison with a control group, p < or = 0.01. The norepinephrine elevation was of greater diagnostic and prognostic importance. Maximum urinary catecholamine metabolite levels occurred between day 3 to 10 after the bleeding. Normetanephrines correlated with the prognosis and the complications of ICH: intraventricular involvement resulted in significantly elevated normetanephrine levels (896 +/- 520 micrograms/day versus 311 +/- 78 micrograms/day) p < or = 0.01. Patients with a great volume of haematoma developed severe autonomic dysregulation (normetanephrines 1114 +/- 493 micrograms/day), whereas patients with smaller haematoma did not (339 +/- 125 micrograms/day) p < or = 0.0001; patients with bad outcome (1014 +/- 620 mg/day) had higher levels of normetanephrines than those with a good prognosis (322 +/- 110 micrograms/day) p < or = 0.001. A close relationship to elevated intracranial pressure was established. This study demonstrated the feasibility of detecting autonomic nervous system dysfunction in neurological intensive care patients by means of examination of the metabolites of the catecholamines in the urine.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Neurology, University of Saarland.
authors.forename: G F
authors.initials: GF
authors.lastname: Hamann
authors.forename: M
authors.initials: M
authors.lastname: Strittmatter
authors.forename: K H
authors.initials: KH
authors.lastname: Hoffmann
authors.forename: G
authors.initials: G
authors.lastname: Holzer
authors.forename: M
authors.initials: M
authors.lastname: Stoll
authors.forename: T
authors.initials: T
authors.lastname: Keshevar
authors.forename: R
authors.initials: R
authors.lastname: Moili
authors.forename: K
authors.initials: K
authors.lastname: Wein
authors.forename: K
authors.initials: K
authors.lastname: Schimrigk
mesh_terms: D000328:Adult; D000368:Aged; D001341:Autonomic Nervous System / Q000503:physiopathology*; D002543:Cerebral Hemorrhage / Q000503:physiopathology*; D003422:Critical Care; D005240:Feasibility Studies; D005260:Female; D006801:Humans; D007427:Intracranial Pressure; D008297:Male; D008676:Metanephrine / Q000652:urine*; D008875:Middle Aged; D009460:Neurologic Examination; D009647:Normetanephrine / Q000652:urine*; D011379:Prognosis; D011446:Prospective Studies
chemical_list: D009647:Normetanephrine; D008676:Metanephrine